Hypoxia has been reported to induce AR signaling in hormone-sensitive LNCaP prostate cancer cells [8,9,10], but it remains unknown whether CRPC cells also utilize this signaling pathway and whether it confers a survival advantage in hypoxia. The gene discussed is AR; the disease is prostate carcinoma.